IB
Incyclix Bio, LLC
SEC filingPharmaceuticals · Durham, NC
Amount raised$11.2Msold at filing
Total offering$20M$8.8M still open
Investors in the raise4count reported to the SEC
FiledAug 22, 2025first sale Aug 6, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Norman N. SharplessDirector
Fredric N. EshelmanExecutive Officer, Director
Patrick RobertsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.